Specialty
Aesthetics Cataract & Refractive Dermatology General Ophthalmology Glaucoma Interventional Radiology Neurology Optometry Retina Women's Health View All Courses
Course Type
Supplement Multimedia Webinar In-Person Multi-Part Collection
Search
Log In

Retina Practice: Anti-VEGF Access and Reimbursement

By: Nathan Steinle, MD (Moderator); David Eichenbaum, MD, FAAO; Sean Goodale, CPA, MBA; Alison L. Ratliff, MBA

Webinar Credits: 1

Program Overview:
This webinar is designed to address the challenges related to anti-VEGF access in retina practices. Hosted by retina specialists and retinal practice CEOs, the program will tackle both clinical and business-related issues including step therapy, MACRA/MIPS, payor-related obstacles, and more. A previously recorded live question-and-answer session will answer many of your questions and concerns.

Target Audience:
This certified CME activity is designed for retina specialists, ophthalmologists, pharmacists, and other professionals involved in the treatment and management of patients with retinal disorders.


Expiration Date: Wednesday, May 19, 2021
Release Date: May 2020

Learning Objectives

Upon completion of this activity, the participant should be able to:

  • Understand and Analyze the potential impact of the Drug Quality and Security Act and identify opportunities to campaign for continued access to compounded ophthalmologic drugs.
  • Recognize how MACRA affects ophthalmology practices and its potential impact on how retina specialists treat their patients with anti-VEGF agents.

 

 

Accreditation and Designation Statement

Provided by Evolve Medical Education

Accreditation Statement

Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

Evolve designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Education Credit

As an independent chartered chapter of the American College of Healthcare Executives, ACHE – SouthEast Texas Chapter is authorized to award 1.0 hours of ACHE Qualified Education credit toward advancement or recertification in the American College of Healthcare Executives.

Participants in this program who wish to have it considered for ACHE Qualified Education credit should list their attendance when they apply to the American College of Healthcare Executives for advancement or recertification.

Please be sure to self-report your credits using link titled “My education Credit” on your myACHE profile page. If additional assistance is needed members should be directed to ACHE Customer Service (contact@ache.org or 312-424-9400).

 

The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

ACPE UAN 0062-9999-20-127-H01-P, 1-hour home study credit (0.1 CE)

Release date: May 19, 2020 Expiration date: May 19, 2021

This application-based activity is accredited for 1 home study contact hour (0.1 CEU) for pharmacists. To claim credit, participants must sign-in/register and participate in the entire activity. No partial credit will be issued.

 

Faculty and Disclosures

Nathan Steinle, MD (Moderator)

California Retina Consultants
Santa Barbara, CA

David Eichenbaum, MD, FAAO

Collaborative Associate Professor
Department of Ophthalmology
University of South Florida Morsani
College of Medicine
Director of Research, Retina Vitreous
Associates of Florida
Tampa, Florida

Sean Goodale, CPA, MBA

Chief Executive Officer
Retina Associates
Kansas City, MO

Alison L. Ratliff, MBA

Chief Executive Officer
South Coast Retina Center
Santa Barbara, CA

 

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity.

The following faculty/staff members have the following financial relationships with commercial interests:

Nathan Steinle, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Genentech, Novartis and Regeneron Pharmaceuticals; Grant Research Support: Genentech, Novartis and Regeneron Pharmaceuticals; Speaker: Genentech, Novartis and Regeneron Pharmaceuticals

David Eichenbaum, MD, FAAO, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alimera Sciences, Allergan, DORC, Eyepoint Pharmaceuticals, Genentech, Gyroscope, Kodiak, Novartis, Recens Medical, and Regeneron Pharmaceuticals; Grant/Research Support: Alimera, Allergan, Chengdu, Clearside Biomedical, Genentech, Gyroscope, Kodiak, Mylan, NGM, Novartis, Opthea, and Ophthotech; Speaker: Allergan, Genentech, and Novartis; Stock/Shareholder: Boston Image Reading Center, Clearside Biomedical, Hemera Biosciences, and Network Eye.

Sean Goodale,CPA, MBA, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Speaker’s Bureau: Genentech, and Regeneron Pharmaceuticals. 

Alison L. Ratliff, MBA, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Novartis, and REGENXBIO Inc; Speaker: Genentech, and Regeneron Pharmaceuticals. 

 

EDITORIAL SUPPORT DISCLOSURES
The staff and planners involved in this activity have no financial relationships with commercial interests.

Caitlin Mardis, PharmD, University of South Carolina College of Pharmacy staff has nothing to disclose.

 

Disclaimer

OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, The University of South Carolina College of Pharmacy, or Regeneron Pharmaceuticals.

Pretest

  • 1. Not at all confident2. Not very confident3. Neutral4. Confident5. Very confident
  • 1. Never2.3. Sometimes4.5. Always

Video Resources

*Note, the question-and-answer session was previously recorded.

Next

Test

Instructions

Step 1 of 2

50%
  • 1. Not at all confident2. Not very confident3. Neutral4. Confident5. Very confident
  • 1. Never2.3. Sometimes4.5. Always
  • AgreeNeutralDisagree
    Understand and Analyze the potential impact of the Drug Quality and Security Act and identify opportunities to campaign for continued access to compounded ophthalmologic drugs.
    Recognize how MACRA affects ophthalmology practices and its potential impact on how retina specialists treat their patients with anti-VEGF agents.
Back